{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:11:40Z","timestamp":1787962300736,"version":"build-2784847793"},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aim<\/jats:title><jats:p>Thiopurines have a favorable benefit\u2013risk ratio in the treatment of inflammatory bowel disease. A feared adverse event of thiopurine therapy is myelotoxicity, mostly occurring due to toxic concentrations of the pharmacologically active metabolites 6\u2010thioguaninenucleotides. In oncology, myelosuppression has also been associated with elevated 6\u2010methylmercaptopurine (6\u2010MMP). In this case series, we provide a detailed overview of 6\u2010MMP\u2010induced myelotoxicity in inflammatory bowel disease patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively scrutinized pharmacological laboratory databases of five participating centers over a 5\u2010year period. Patients with leukocytopenia at time of elevated 6\u2010MMP levels (&gt;5700\u00a0pmol\/8\u00a0\u00d7\u00a010<jats:sup>8<\/jats:sup> red blood cells) were included for detailed chart review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this case series, we describe demographic, clinical, and pharmacological aspects of 24 cases of 6\u2010MMP\u2010induced myelotoxicity on weight\u2010based thiopurine therapy with a median steady\u2010state 6\u2010MMP level of 14\u00a0500\u00a0pmol\/8\u00a0\u00d7\u00a010<jats:sup>8<\/jats:sup> red blood cells (range 6600\u201348\u00a0000). All patients developed leukocytopenia (white blood cell count 2.7\u00a0\u00b1\u00a00.9\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/L) after a median period of 11\u00a0weeks after initiation of thiopurine therapy (interquartile range 6\u201346\u00a0weeks). Eighteen patients (75%) developed concurrent anemia (median hemoglobin concentration 6.9\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/L), and four patients developed concurrent thrombocytopenia (median platelet count 104\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/L). Leukocytopenia resolved in 20 patients (83%) within 4\u00a0weeks upon altered thiopurine treatment regimen, and white blood cell count was increasing, but not yet normalized, in the remaining four patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We observed that thiopurine\u2010induced myelotoxicity also occurs because of (extremely) high 6\u2010MMP concentrations in patients with a skewed thiopurine metabolism. Continued treatment with adapted thiopurine therapy was successful in almost all patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jgh.13656","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T04:12:39Z","timestamp":1479355959000},"page":"1183-1190","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["6\u2010methylmercaptopurine\u2010induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients"],"prefix":"10.1111","volume":"32","author":[{"given":"Berrie","family":"Meijer","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology VU University Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joany E","family":"Kreijne","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia A W","family":"van Moorsel","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacology and Toxicology Zuyderland Medical Center  Heerlen\u2010Sittard\u2010Geleen The Netherlands"},{"name":"Department of Clinical Pharmacy Maastricht University Medical Center  Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J J","family":"Derijks","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy M\u00e1xima Medical Center  Veldhoven The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Bouma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology VU University Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J J","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology VU University Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacology and Toxicology Zuyderland Medical Center  Heerlen\u2010Sittard\u2010Geleen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Janneke","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A","family":"van Bodegraven","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology VU University Medical Center  Amsterdam The Netherlands"},{"name":"Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co\u2010MIK) Zuyderland Medical Center  Heerlen\u2010Sittard\u2010Geleen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanne K H","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology VU University Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000545"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.09.002"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.12.002"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.10.4986"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328334338f"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920009790711887"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep1000"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16432"},{"key":"e_1_2_6_10_1","first-page":"5810","article-title":"Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells","volume":"61","author":"Dervieux T","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05084.x"},{"key":"e_1_2_6_12_1","first-page":"222","article-title":"High TPMT activity as a risk factor for severe myelosuppression during thiopurine therapy","volume":"71","author":"Seinen ML","year":"2013","journal-title":"Neth. J. Med."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03925.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02977.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.082909"},{"key":"e_1_2_6_16_1","first-page":"505","article-title":"Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease","volume":"4","author":"Sparrow MP","year":"2008","journal-title":"Gastroenterol. Hepatol. (N Y)."},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03812.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02630.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01511.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.050831"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80347-S"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00024"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.2.260"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2010.03.004"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.05.026"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.155"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2717-8"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04221.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.23021"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.06.002"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.597371"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.12.006"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.07.009"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f28f"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01848.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13796"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70140-5"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2016.1161068"},{"key":"e_1_2_6_39_1","article-title":"Early assessment of thiopurine Metabolites identifies patients at risk of thiopurine\u2010induced leukopenia in inflammatory bowel disease","author":"Wong DR","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000213"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12467"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70354-4"},{"key":"e_1_2_6_43_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.15403\/jgld.2014.1121.252.nud","article-title":"NUDT15: a novel player in thiopurine metabolism","volume":"25","author":"Meijer B","year":"2016","journal-title":"J. Gastrointestin. Liver Dis."}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgh.13656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgh.13656","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.13656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgh.13656","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.13656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T22:40:52Z","timestamp":1694212852000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgh.13656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1111\/jgh.13656"],"URL":"https:\/\/doi.org\/10.1111\/jgh.13656","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]},"assertion":[{"value":"2016-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}